Pomalidomide in Gene Expression Profiling (GEP)-Defined High-risk Multiple Myeloma
Clinical trial NCT01177735 · COMPLETED
Trial details
- NCT number
- NCT01177735
- Sponsor
- University of Arkansas
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2013-09-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.